UCB To SHAPE Up With Cost-Cutting Plan, Two Years After Schwarz Buy

UCB is joining the ranks of pharma companies embarking on major cost cutting programs, as the Belgian company decides to focus on specialty markets two years after bulking up via the acquisition of Schwarz Pharma